- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Sitting Position in United States
Total 2421 results
-
Laura Huppert, MD, BAAmbrx, Inc.Not yet recruitingARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast CancerTriple Negative Breast Cancer | Hormone Receptor Positive Breast Carcinoma | HER2 Low Breast Carcinoma | Hormone-receptor-positive Breast CancerUnited States
-
University of North Carolina, Chapel HillCompletedChild Behavior Problem | Positive Parenting | Program ImplementationUnited States
-
Bill & Melinda Gates Medical Research InstituteMerck Sharp & Dohme LLCRecruitingTuberculosisUnited States
-
Fred Hutchinson Cancer CenterMerck Sharp & Dohme LLCCompleted
-
National Institute of Allergy and Infectious Diseases...University of Pennsylvania; Emory University; University of Florida; Aurum InstituteCompleted
-
BlueWillow BiologicsPorton Biopharma Ltd.Completed
-
Medical College of WisconsinCompletedClostridium Difficile InfectionUnited States
-
National Cancer Institute (NCI)Completed
-
Global Alliance for TB Drug DevelopmentCompleted
-
Global Alliance for TB Drug DevelopmentCompleted
-
Global Alliance for TB Drug DevelopmentCompletedFood Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects (CL-003)TuberculosisUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)RecruitingBiodistribution and Pharmacokinetics of Pretomanid in Tuberculosis Patients Using 18F-Pretomanid PETTuberculosisUnited States
-
VA Office of Research and DevelopmentTerminatedMicrobiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH) (MATCH)Clostridium Difficile InfectionUnited States
-
Emergent BioSolutionsNational Institutes of Health (NIH)CompletedAnthraxUnited States
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosisUnited States
-
QIAGEN Gaithersburg, IncCompleted
-
QIAGEN Gaithersburg, IncCompleted
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Withdrawn
-
Montefiore Medical CenterMerck Sharp & Dohme LLCTerminatedClostridium DifficileUnited States
-
Crouse HospitalJana Shaw, MD; Steven Gross, MD; David Martin, RN; Dale Franz, RPh; Rachel CareyCompletedStaphylococcusUnited States
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
AerasCompleted
-
Pfenex, IncDepartment of Health and Human ServicesCompleted
-
PharmAthene, Inc.National Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaboratorsCompleted
-
PharmAthene, Inc.Quintiles, Inc.; National Institutes of Health (NIH); Department of Health and... and other collaboratorsSuspended
-
University of UtahCompletedNewly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast CancerUnited States
-
SanofiCompletedClostridium InfectionsUnited States
-
Vanderbilt-Ingram Cancer CenterActive, not recruitingEstrogen Receptor-positive Breast CancerUnited States
-
David SuskindPacific Northwest National LaboratoryCompletedDiet Modification | Clostridium Difficile InfectionUnited States
-
University of Wisconsin, MadisonCompleted
-
The University of Texas Health Science Center,...CompletedPregnancy | Streptococcus InfectionUnited States
-
Ohio State UniversityNational Institute on Drug Abuse (NIDA); Massachusetts General Hospital; University... and other collaboratorsRecruitingHIV-positive IndividualsUnited States
-
National Cancer Institute (NCI)CompletedChronic Phase Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
GeneQuantum Healthcare (Suzhou) Co., Ltd.RecruitingHER2-positive Breast Cancer | HER2-positive Biliary Tract Cancer | HER2-Positive Salivary Gland Carcinomas | HER2-Positive Advanced Solid TumorChina, Australia, United States
-
National Institute of Allergy and Infectious Diseases...Completed
-
University of California, Los AngelesRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Previously Treated Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome and other conditionsUnited States
-
University of Maryland, BaltimoreCompleted
-
M.D. Anderson Cancer CenterActive, not recruitingAcute Lymphoblastic Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Acute Myeloid Leukemia With BCR-ABL1United States
-
Cubist Pharmaceuticals LLCCompleted
-
Melinta Therapeutics, LLCRecruitingGram Positive Bacterial InfectionsUnited States
-
Silverback TherapeuticsTerminatedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Colorectal Cancer | HER2-expressing Non-small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); PfizerTerminatedChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blasts Under 15 Percent of Bone Marrow Nucleated Cells | Blasts Under 15 Percent of Peripheral Blood White Cells | Blasts Under 30 Percent of Bone Marrow Nucleated Cells | Blasts Under 30 Percent of Peripheral Blood White CellsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteVaccinex Inc.RecruitingHER2-positive Breast CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteImmunoRestorationRecruitingHER2-positive Breast CancerUnited States
-
University of Alabama at BirminghamRecruitingHER2-positive Breast CancerUnited States